News
Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback